Guardant Health Appoints Richard Lanman, M.D. as Chief Medical Officer

REDWOOD CITY, Calif., Sept. 8, 2014 /PRNewswire/ -- Guardant Health, a healthcare company focused on the development and commercialization of non-invasive tumor sequencing tests, today announced that Richard Lanman, M.D., has been appointed Chief Medical Officer. In this role, Dr. Lanman will lead Guardant Health's strategic initiatives in managed care.

"We are very pleased to have Rick joining the Guardant Health team," said Helmy Eltoukhy, PhD, CEO and co-Founder of Guardant Health. "Rick's proven track record of successfully securing positive coverage for innovative diagnostic tests and extensive work in clinical utility studies will be of great benefit as we continue the commercialization and market adoption of Guardant360^®, the first non-invasive, comprehensive tumor sequencing test." 

Prior to joining Guardant Health, Dr. Lanman was chief medical officer for Veracyte where he successfully conducted several large multicenter clinical utility and validity studies in endocrinology and pulmonology. He led collaborations with key academic and community-based opinion leaders that led to broad managed care coverage for the Afirma™ thyroid cancer test.  He has held CMO and Executive Vice President roles at several cardiovascular diagnostics companies, including diaDexus, Inc. and Atherotech.  Earlier in his career, he served in various physician practice management roles.  Dr. Lanman is also currently on the board of advisors for Compass Technology Partners.

About Guardant Health

Guardant Health is focused on developing breakthrough diagnostic technologies that possess the ability to transform cancer from a terminal illness to a manageable disease.  Guardant was founded in 2012 by a team of entrepreneurs with cutting edge expertise in next-generation sequencing, single-cell genomics and cancer diagnostics.  Guardant Health is committed to contributing a positive significant impact on patient health through cutting-edge technology that addresses long-standing unmet needs in oncology.    (www.guardanthealth.com)

Logo - http://photos.prnewswire.com/prnh/20140212/SF64352LOGO

SOURCE Guardant Health